View Author
g-csf patient leukemia group factor granulocyte colony-stimulating factor myeloid leukemia survival chemotherapy percent cycle effect myeloid copyright 2003 massachusetts colony-stimulating hospital remission square meter treatment death study disease-free survival cytarabine granulocyte disease-free granulocyte-macrophage colony-stimulating factor www.nejm.org induction event hematopoietic growth factors cytosine arabinoside university relapse gm-csf center hematopoietic table growth square g-csf group meter induction chemotherapy outcome erasmu society cox regression analysis analysis blood cycles 1 hematopoietic recovery lberg massachusett copyright cytogenetic hematology month cytosine event-free survival universiteit millimeter department recovery biblio right november downloaded england journal arabinoside medisch cause leukemic cells event-free leukemic prognostic netherland cancer idarubicin switzerland therapy amsacrin
5 Most Recent Publications
|
Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40
(Article)
Rijneveld, A.W. Holt, B. van der Wijermans, P. Wittebol, S. Spoelstra, F.M. Dekker, A.W. Ossenkoppele, G.J. Willemze, R. Cornelissen, J.J. Daenen, S.M.G.J. Biemond, B.J. de Weerdt, O. Muus, P. Maertens, J. Mattijssen, V. Demuynck, H. Legdeur, M.C.J.C. |
2011-06-07
|
|
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
(Article)
Deenik, W. Janssen, J.J.W.M. Sonneveld, P. Marwijk Kooy, M. van Wittebol, S. Willemze, R. Wijermans, P.W. Beverloo, H.B. Löwenberg, B. Valk, P.J.M. Ossenkoppele, G.J. Cornelissen, J.J. Holt, B. van der Verhoef, G.E.G. Smit, W.M. Kersten, M.J. Daenen, S.M.G.J. Verdonck, L.F. Ferrant, A. Schattenberg, A.V.M.B. |
2010-06-01
|
|
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: Benefits for whom?
(Article)
Cornelissen, J.J. Putten, W.L.J. van Lelie, H. van der Fey, M. Ferrant, A. Maertens, J. Gratwohl, A. Löwenberg, B. Verdonck, L.F. Theobald, M. Jacky, E. Daenen, S.M.G.J. Marwijk Kooy, M. van Wijermans, P.W. Schouten, H. Huijgens, P.C. |
2007-05-01
|
|
High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study
(Article)
Deenik, W. Holt, B. van der Schouten, H. Löwenberg, B. Ossenkoppele, G.J. Cornelissen, J.J. Verhoef, G.E.G. Schattenberg, A.V.M.B. Verdonck, L.F. Daenen, S.M.G.J. Zachée, P. Westveer, P.H.M. Smit, W.M. Wittebol, S. |
2007-02-01
|
|
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia
(Article)
Löwenberg, B. Kovacsovics, T. Daenen, S.M.G.J. Ferrant, A. Gratwohl, A. Greef, G.E. de Putten, W.L.J. van Theobald, M. Gmur, J. Boogaerts, M. Verdonck, L.F. Sonneveld, P. Fey, M.F. Huijgens, P. |
2003-01-01
|
